[] RESEARCH EVIDENCE OF N-ACETYL CYSTEINE ON OBSESSIVE COMPULSIVE DISORDER Uncontrolled In the first case report to be published, a 58-year-old woman with fluvoxamine-refractory OCD was successfully treated with NAC for 12 weeks (NAC was titrated from 600 mg daily to 3 g/day), and her OCD symptoms significantly improved during the study period
For BPC-157 and other experimental peptides, clinical evidence is largely absent
Recalls & Warnings May 11, 2006 Weight-Loss Marketers Pay $3 Million for Deceptive Advertising On May 11, the Federal Trade Commission (FTC) announced that sellers making questionable weight-loss and fat-loss claims to peddle skin gels and diet supplements will pay $3 million to settle charges that their deceptive claims violated federal law
From our perspective IGF-1, GH, and insulin conform a finely regulated axis that inform cells about the nutritional status of the organism so that they can either undergo apoptosis/senescence/quiescence or, to the contrary, grow and differentiate
Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions
It may be especially helpful for athletes, patients seeking rehabilitation, orindividuals with high oxidative stress markers and inflammatory concerns.